Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Medicus Pharma Ltd ( (MDCX) ) is now available.
Medicus Pharma will host a March 26 business update webcast featuring Dr. Babar K. Rao, principal investigator and key opinion leader in dermatologic oncology, to discuss Phase 2 results for its SkinJect microneedle-delivered doxorubicin in nodular basal cell carcinoma. The randomized, double-blind SKNJCT-003 trial showed 73% clinical clearance and 40% histological clearance at Day 57 in the 200-µg cohort, with a clear efficacy separation from the device-only arm, supporting SkinJect’s potential as a non-surgical treatment option and providing decision-grade evidence for regulatory dialogue and strategic partnerships.
The most recent analyst rating on (MDCX) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Medicus Pharma Ltd stock, see the MDCX Stock Forecast page.
Spark’s Take on MDCX Stock
According to Spark, TipRanks’ AI Analyst, MDCX is a Neutral.
The score is primarily constrained by weak financial performance (no revenue, widening losses, and heavy cash burn with negative equity) and bearish technicals (price below all major moving averages with negative MACD). Valuation is difficult to assess due to negative earnings and no dividend support, while recent financing provides some liquidity benefit but reinforces dilution/financing dependence.
To see Spark’s full report on MDCX stock, click here.
More about Medicus Pharma Ltd
Medicus Pharma Ltd., listed on Nasdaq under the ticker MDCX, is a biotech and life sciences company developing novel therapeutic assets with a focus on disruptive treatment platforms. Its SkinJect microneedle technology targets dermatologic oncology indications such as basal cell carcinoma, aiming to deliver minimally invasive alternatives to traditional surgical procedures.
Average Trading Volume: 3,728,430
Technical Sentiment Signal: Sell
Current Market Cap: $13.94M
For an in-depth examination of MDCX stock, go to TipRanks’ Overview page.